Clinical Trial Update: A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating tolerability of different doses of BI 754132 in geographic atrophy due to age-related macular degeneration; trial terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• BI 754132 (BI 754132)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Macular Degeneration | Phase 1 | Status: TERMINATED | Results posted: 2023-09-15